共 50 条
- [8] Canakinumab for Pulmonary Artery Hypertension and Macrophage Activation Syndrome Associated with Uncontrolled Systemic Juvenile Idiopathic Arthritis [J]. Indian Journal of Pediatrics, 2021, 88 : 608 - 609
- [9] Canakinumab for Pulmonary Artery Hypertension and Macrophage Activation Syndrome Associated with Uncontrolled Systemic Juvenile Idiopathic Arthritis [J]. INDIAN JOURNAL OF PEDIATRICS, 2021, 88 (06): : 608 - 609
- [10] Standard and increased canakinumab dosing to quiet macrophage activation syndrome in children with systemic juvenile idiopathic arthritis [J]. FRONTIERS IN PEDIATRICS, 2022, 10